Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Integrating network pharmacology with molecular docking analysis, five candidate bioactive compoundsincluding Cubebin and dihydrochalcone derivativeswere identified as targeting key pathogenic proteins such as TP53, SRC, STAT3, PIK3CA, and AKT1 (220)
Kulkarni A, Bowers LW
References National Center for Biotechnology Information
I saw results realky quickly
Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2
Dont Miss a Beat on New Treatments & Research: Sign up for a Free Membership today
US$ 27.86
US$ 29.94
US$ 22.69
US$ 24.10
US$ 23.90
US$ 24.18
